Aprile Pilon

Chief Executive Officer at Trove Therapeutics, Inc.

Aprile Pilon is a seasoned professional currently serving as the Founder & Acting Chief Executive Officer at Trove Therapeutics, a clinical-stage biopharmaceutical company focused on transforming the management of respiratory diseases.

With an academic background in Cell/Cellular and Molecular Biology and Physics, Aprile holds a Doctor of Philosophy (PhD) from Pennsylvania State University-College Park and a Bachelor of Arts (BA) from Wheaton College Massachusetts.

Prior to her current role, Aprile has been involved in various entrepreneurial ventures and leadership positions within the biotechnology and healthcare industry. She served as a Co-founder of Empower Telehealth, Founder of APCBio Innovations, and held executive roles at Therabron Therapeutics and APC BIOTECHNOLOGY SERVICES.

Trove Therapeutics is pioneering the development of a new class of drugs derived from the secretoglobin family of proteins. Their lead product, recombinant human SCGB1A1 protein (rhSCGB1A1), shows promising potential as an anti-inflammatory agent for patients with respiratory diseases.

Aprile Pilon's extensive experience in biopharmaceuticals and her dedication to innovative solutions make her a key figure in the realm of healthcare and biotechnology.

Aprile's educational achievements and professional endeavors highlight her commitment to advancing medical treatments and improving health outcomes for individuals suffering from respiratory ailments.